Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
6 Apr 2025
Preoperative Allergy Delabelling: A Safe and Feasible Approach
The study also highlighted a reduction in restricted antibiotic use among patients in the intervention group compared with the control group.
5 Apr 2025
Metabolic Imaging Enhances Liver Function Assessment Pre-Surgery
Discover a project that designed EchoNet-Liver, a deep-learning computer-vision pipeline to cirrhosis and steatotic liver disease.
5 Apr 2025
Genetic Study Reveals 60 Key Genes Driving Congenital Heart Disease
Discover how 60 genes drive congenital heart disease. Learn how genetic testing improves outcomes.
5 Apr 2025
Patient Perceptions Linked to Rheumatoid Arthritis Diagnosis Delays
A Danish study finds that symptom interpretation and beliefs about treatment impact how quickly patients with early rheumatoid arthritis seek medical help.
5 Apr 2025
IL-33 Inhibition Shows Promise in High-Risk COPD
IL-33 inhibition with tozorakimab may offer clinical benefits in patients with COPD at high risk of exacerbations.
5 Apr 2025
Ensitrelvir Significantly Reduces COVID-19 Transmission in Households
Ensitrelvir reduces risk of COVID-19 in household contacts when administered within 72 hours of symptom onset.
5 Apr 2025
High Glycaemic Diet Linked to Pancreatic Fat Buildup
A new study links high glycemic index and load diets with increased risk of pancreatic steatosis, while fibre intake appears protective.
5 Apr 2025
Intermittent Fasting and HIIT for Postmenopausal Metabolic Health
Discover a study that explores the effect of intermittent fasting and HIIT on body recomposition in postmenopausal women.
4 Apr 2025
PCI in Patients with Blood Cancer: New Insights on Risks
Patients with myeloproliferative neoplasms face higher acute kidney injury and transfusion risks post-PCI, according to a 2.24M hospitalisation study.
AstraZeneca’s NSCLC drug approved by European Commission
The European Commission has approved a new regimen from AstraZeneca, which combines the company’s durvalumab with chemotherapy for patients with resectable NSCLC
←
1
2
3
…
24
25
26
27
28
29
30
…
1,105
1,106
1,107
→
We’ve noticed you’re accessing
from
North/South America.
View
View